Abstract:The fabrication and structural identification of mixed ligand chelates resulting from 1-(1H-benzimidazol-2-yl) guanidine (BIG = main ligand) and 1,10-Phenanthroline (phen) (secondary ligand). The tested compounds were investigated using TGA, CHN, spectra analysis (FT-IR, Mass spectra, NMR), melting point, magnetic moments, molar conductance, Ultraviolet–Visible spectroscopy as well computational studies. The conductance results showed that the tested Pd(II), VO(II) and Ag(I) chelates have electrolytes in fresh solutions of DMSO lies in the range 38.12–118.87 Ω −1 cm 2 mol −1 except, Cu(II) chelate is a non-electrolyte it is value equal 15.16 Ω −1 cm 2 mol −1 . FT-IR spectrum displays that the tested main ligand is coordinated with metal ions in a bi-dentate behavior with N, N donor sites of the HN=C and C=N. While the second ligand coordinated with metal ions through its N 2 atom in the pyridine ring. Moreover, the obtained analytical data regarding complexation in solution, molar ratio and continuous variation methods suggest 1M: 1 L molar ratio. Also the stability constant of tested complexes was identified in solution state and the formation constants (Kf) were evaluated by applying continuous-variation method. Stability of complexes was arranged by BIGPAg > BIGPVO > BIGPCu > BIGPPPd in agreement with K f values. The pH profile revealed that the wide range of pH stability of the tested complexes is at pH = 4- 10 in most of them. Magnetic and electronic spectra are applied to deduce the coordinating ability of the tested ligands and the geometric structure of the studied chelates. That data of magnetic susceptibility for ternary mixed chelates are locked to an octahedral geometry for Cu(II) & VO(II) chelates due to the data of (μeff = 1.8 and 1.83 B.M) respectively and Pd(II) and Ag(I) chelates are diamagnetic with square planar and tetrahedral geometry, respectively. The TGA study of these studied complexes displays that the hydrated H 2 O, acetate, nitrate, and acetylacetonate anions are removed in the first (45°C-180°C) and second degradation steps followed directly by degradation of the studied ligands in the following stages. The thermodynamic factors, like ΔS*, ΔH*, E*, A and ΔG* are evaluated from the TGA curves and explained. The DFT/B3LYP computation method was applied for the estimation of the MEP, (HUMO & LUMO) energy for the studied compounds. In-silico assay was executed by two different approaches over compounds to evaluate their biological behavior and degree of interaction with biological systems, before practical application. BIGPPd complex displayed priority in interaction with various protein. In-vitro assay was then carried out for compounds against different microbes and BIGPPd showed high antimicrobial activity with inhibition zones are established to be 45.75 ± 0.10 and 41.95 ± 0.05 mm against B. Cereus and G. Candidum at 25 μg/mL. Also, their cytotoxic behavior was examined against MCF-7, HepG2 and HCT-116 carcinoma cell lines, high cytotoxicity was clearly recorded with BIGPPd complex with IC 50 % are established to be (5, 6.25 and 7.14 μg/mL) respectively. Furthermore, antioxidant activity was examined, and the complexes exhibited high reactivity with trapping free radicals. The BIGPPd exhibited significant free radical scavenging activity with an IC 50 value of 20.15 μg/ml. The interaction of metal chelates with DNA was detected by gel electrophoreses, viscosity and spectral studies. Spectrophotometric titration and viscosity studies expose that each of tested complex is an avid binder to DNA. The intrinsic binding constants were calculated for all the tested compounds could bind to Ct-DNA generally through replacement, intercalative mode & minor groove binding of interactions with the sequence: BIGPVO (6.05×10 4 ) > BIGPCu > BIGPPd> BIGPAg >BIG (1.16×10 3 ). This may be due to enhanced hydrophobic & electrostatic interaction of aromatic rings. Finally, such complexes may be considered as a promising bioactive agent.

Synthesis and characterization of mixed-ligand Co(II) complexes with gabapentin or pregabalin and diimine coligands: DNA interaction, antibacterial, antifungal and molecular docking studies

Studies of the molecular docking, antibacterial, antifungal, and DNA interaction of mixed-ligand Ni(II) complexes with gabapentin or pregabalin and diimine coligands

Antibacterial Activity of Co(III) Complexes with Diamine Chelate Ligands against a Broad Spectrum of Bacteria with a DNA Interaction Mechanism

Preparation, Characterization, DFT Calculations, Antibacterial and Molecular Docking Study of Co(II), Cu(II), and Zn(II) Mixed Ligand Complexes

Synthesis, DFT, Molecular Docking, and Antimicrobial Studies of New Indole-Thiosemicarbazone Ligand and Their Complexes with Fe(III), Co(II), Ni(II), Cu(II)

Fabrication, physicochemical characterization and theoretical studies of some new mixed ligands complexes based on N-(1H-benzimidazol-2-yl)-guanidine and 1, 10-phenanthroline: DNA interaction, biological applications and molecular docking approach

Synthesis, Spectroscopic, Computational Structure Analysis, Molecular Docking, in vitro Antibacterial and in vivo Antipyretic Investigations of Transition Metal(II) Complexes

Crystal structure, Hirshfeld surface analysis, molecular modeling, electrochemical properties, and of a novel binuclear Co(II) complex

Co (II), Ni (II), and Cu (II) ternary complexes with 2,6‐pyridinedicarboxylic acid: Thermal decomposition, DNA interaction, and biological activity studies

Synthesis, characterization, biological potency, and molecular docking of Co2+, Ni2+ and Cu2+ complexes of a benzoyl isothiocyanate based ligand

Synthesis and characterization of a cobalt(II) complex with 5-amino-1-tosyl-1h-1,2,4-triazole as a sulfonamide ligand: antibacterial and molecular docking studies

Synthesis, characterization, and antibacterial activity studies of two Co(II) complexes with 2-[(E)-(3-acetyl-4-hydroxyphenyl)diazenyl]-4-(2-hydroxyphenyl)thiophene-3-carboxylic acid as a ligand

SYNTHESIS, CHARACTERIZATION, PREPARATION AND EVALUATION OF THE BACTERICIDAL POTENTIAL OF TWO Co+2 COMPLEXES USING LIGANDS 4-AMINOPYRIDINE AND 2,2'-BIPYRIDINE

Novel metal(II) complexes with pyrimidine derivative ligand: synthesis, multi-spectroscopic, DNA binding/cleavage, molecular docking with DNA/BSA, and antimicrobial studies

Synthesis, spectroscopic characterization, computational studies, theoretical investigation of NLO properties and antibacterial activities of mixed ligand complexes of Co(II) and Cu(II)

Co(II), Ni(II), Cu(II) and Zn(II) complexes of 1,8-naphthalimide-based ligand: syntheses, characterizations and evaluation of antibacterial activities

Geometry optimization and energy parameter calculations using density-functional theory method and molecular docking of anticonvulsant therapeutic metal complexes of gabapentin

Synthesis, characterization, and biological activity of new mixed ligand transition metal complexes of glutamine, glutaric, and glutamic acid with nitrogen based ligands

Novel 1,3‐diphenyl‐4‐(N,N‐dimethylimido dicarbonimidic diamide azo)‐5‐pyrazolone and its chelates with manganese, nickel, copper, and zinc divalent metal ions as an antibacterial activity supported by molecular docking studies: Design, synthesis, DFT, and TD‐DFT/PCM calculations

Innovation, structural inspection for new mixed complexes: DNA binding, biomedical applications and molecular docking approaches

Synthesis, characterization and antioxidant, antibacterial activity Zn2+, Cu2+, Ni2+ and Co2+, complexes of ligand [2-(thiophen-2-yl)-1-(thiophen-2-ylmethyl)-1H-benzo[d]imidazole]